ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global New Psychoactive Substance Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27D7124
Home | Market Reports | Sensitive Subjects
Global New Psychoactive Substance Market Insights Forecast to 2028
BUY CHAPTERS

Global New Psychoactive Substance Market Research Report 2025

Code: QYRE-Auto-27D7124
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies

New Psychoactive Substance Market

The global market for New Psychoactive Substance was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for New Psychoactive Substance is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for New Psychoactive Substance is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for New Psychoactive Substance in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of New Psychoactive Substance include Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences, AusCann, Cannabics Pharmaceuticals, Tilray, Cyrelian, Anandia Laboratories, InMed Pharmaceuticals, Renew Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for New Psychoactive Substance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Psychoactive Substance.
The New Psychoactive Substance market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global New Psychoactive Substance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the New Psychoactive Substance companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of New Psychoactive Substance Market Report

Report Metric Details
Report Name New Psychoactive Substance Market
Segment by Type
  • Stimulants
  • Cannabinoids
  • Hallucinogens
  • Depressants
Segment by Application
  • Cancer
  • Neuropathic Disorders
  • Spasticity
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences, AusCann, Cannabics Pharmaceuticals, Tilray, Cyrelian, Anandia Laboratories, InMed Pharmaceuticals, Renew Biopharma, Cronos Group, ICC International Cannabis, Biotii Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of New Psychoactive Substance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the New Psychoactive Substance Market report?

Ans: The main players in the New Psychoactive Substance Market are Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences, AusCann, Cannabics Pharmaceuticals, Tilray, Cyrelian, Anandia Laboratories, InMed Pharmaceuticals, Renew Biopharma, Cronos Group, ICC International Cannabis, Biotii Technologies

What are the Application segmentation covered in the New Psychoactive Substance Market report?

Ans: The Applications covered in the New Psychoactive Substance Market report are Cancer, Neuropathic Disorders, Spasticity, Others

What are the Type segmentation covered in the New Psychoactive Substance Market report?

Ans: The Types covered in the New Psychoactive Substance Market report are Stimulants, Cannabinoids, Hallucinogens, Depressants

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Psychoactive Substance Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stimulants
1.2.3 Cannabinoids
1.2.4 Hallucinogens
1.2.5 Depressants
1.3 Market by Application
1.3.1 Global New Psychoactive Substance Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Neuropathic Disorders
1.3.4 Spasticity
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Psychoactive Substance Market Perspective (2020-2031)
2.2 Global New Psychoactive Substance Growth Trends by Region
2.2.1 Global New Psychoactive Substance Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 New Psychoactive Substance Historic Market Size by Region (2020-2025)
2.2.3 New Psychoactive Substance Forecasted Market Size by Region (2026-2031)
2.3 New Psychoactive Substance Market Dynamics
2.3.1 New Psychoactive Substance Industry Trends
2.3.2 New Psychoactive Substance Market Drivers
2.3.3 New Psychoactive Substance Market Challenges
2.3.4 New Psychoactive Substance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Psychoactive Substance Players by Revenue
3.1.1 Global Top New Psychoactive Substance Players by Revenue (2020-2025)
3.1.2 Global New Psychoactive Substance Revenue Market Share by Players (2020-2025)
3.2 Global New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by New Psychoactive Substance Revenue
3.4 Global New Psychoactive Substance Market Concentration Ratio
3.4.1 Global New Psychoactive Substance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Psychoactive Substance Revenue in 2024
3.5 Global Key Players of New Psychoactive Substance Head office and Area Served
3.6 Global Key Players of New Psychoactive Substance, Product and Application
3.7 Global Key Players of New Psychoactive Substance, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 New Psychoactive Substance Breakdown Data by Type
4.1 Global New Psychoactive Substance Historic Market Size by Type (2020-2025)
4.2 Global New Psychoactive Substance Forecasted Market Size by Type (2026-2031)
5 New Psychoactive Substance Breakdown Data by Application
5.1 Global New Psychoactive Substance Historic Market Size by Application (2020-2025)
5.2 Global New Psychoactive Substance Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America New Psychoactive Substance Market Size (2020-2031)
6.2 North America New Psychoactive Substance Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America New Psychoactive Substance Market Size by Country (2020-2025)
6.4 North America New Psychoactive Substance Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Psychoactive Substance Market Size (2020-2031)
7.2 Europe New Psychoactive Substance Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe New Psychoactive Substance Market Size by Country (2020-2025)
7.4 Europe New Psychoactive Substance Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New Psychoactive Substance Market Size (2020-2031)
8.2 Asia-Pacific New Psychoactive Substance Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific New Psychoactive Substance Market Size by Region (2020-2025)
8.4 Asia-Pacific New Psychoactive Substance Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New Psychoactive Substance Market Size (2020-2031)
9.2 Latin America New Psychoactive Substance Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America New Psychoactive Substance Market Size by Country (2020-2025)
9.4 Latin America New Psychoactive Substance Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Psychoactive Substance Market Size (2020-2031)
10.2 Middle East & Africa New Psychoactive Substance Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa New Psychoactive Substance Market Size by Country (2020-2025)
10.4 Middle East & Africa New Psychoactive Substance Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Details
11.1.2 Zynerba Pharmaceuticals Business Overview
11.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Introduction
11.1.4 Zynerba Pharmaceuticals Revenue in New Psychoactive Substance Business (2020-2025)
11.1.5 Zynerba Pharmaceuticals Recent Development
11.2 GW Pharmaceuticals
11.2.1 GW Pharmaceuticals Company Details
11.2.2 GW Pharmaceuticals Business Overview
11.2.3 GW Pharmaceuticals New Psychoactive Substance Introduction
11.2.4 GW Pharmaceuticals Revenue in New Psychoactive Substance Business (2020-2025)
11.2.5 GW Pharmaceuticals Recent Development
11.3 Teewinot Life Sciences
11.3.1 Teewinot Life Sciences Company Details
11.3.2 Teewinot Life Sciences Business Overview
11.3.3 Teewinot Life Sciences New Psychoactive Substance Introduction
11.3.4 Teewinot Life Sciences Revenue in New Psychoactive Substance Business (2020-2025)
11.3.5 Teewinot Life Sciences Recent Development
11.4 AusCann
11.4.1 AusCann Company Details
11.4.2 AusCann Business Overview
11.4.3 AusCann New Psychoactive Substance Introduction
11.4.4 AusCann Revenue in New Psychoactive Substance Business (2020-2025)
11.4.5 AusCann Recent Development
11.5 Cannabics Pharmaceuticals
11.5.1 Cannabics Pharmaceuticals Company Details
11.5.2 Cannabics Pharmaceuticals Business Overview
11.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Introduction
11.5.4 Cannabics Pharmaceuticals Revenue in New Psychoactive Substance Business (2020-2025)
11.5.5 Cannabics Pharmaceuticals Recent Development
11.6 Tilray
11.6.1 Tilray Company Details
11.6.2 Tilray Business Overview
11.6.3 Tilray New Psychoactive Substance Introduction
11.6.4 Tilray Revenue in New Psychoactive Substance Business (2020-2025)
11.6.5 Tilray Recent Development
11.7 Cyrelian
11.7.1 Cyrelian Company Details
11.7.2 Cyrelian Business Overview
11.7.3 Cyrelian New Psychoactive Substance Introduction
11.7.4 Cyrelian Revenue in New Psychoactive Substance Business (2020-2025)
11.7.5 Cyrelian Recent Development
11.8 Anandia Laboratories
11.8.1 Anandia Laboratories Company Details
11.8.2 Anandia Laboratories Business Overview
11.8.3 Anandia Laboratories New Psychoactive Substance Introduction
11.8.4 Anandia Laboratories Revenue in New Psychoactive Substance Business (2020-2025)
11.8.5 Anandia Laboratories Recent Development
11.9 InMed Pharmaceuticals
11.9.1 InMed Pharmaceuticals Company Details
11.9.2 InMed Pharmaceuticals Business Overview
11.9.3 InMed Pharmaceuticals New Psychoactive Substance Introduction
11.9.4 InMed Pharmaceuticals Revenue in New Psychoactive Substance Business (2020-2025)
11.9.5 InMed Pharmaceuticals Recent Development
11.10 Renew Biopharma
11.10.1 Renew Biopharma Company Details
11.10.2 Renew Biopharma Business Overview
11.10.3 Renew Biopharma New Psychoactive Substance Introduction
11.10.4 Renew Biopharma Revenue in New Psychoactive Substance Business (2020-2025)
11.10.5 Renew Biopharma Recent Development
11.11 Cronos Group
11.11.1 Cronos Group Company Details
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group New Psychoactive Substance Introduction
11.11.4 Cronos Group Revenue in New Psychoactive Substance Business (2020-2025)
11.11.5 Cronos Group Recent Development
11.12 ICC International Cannabis
11.12.1 ICC International Cannabis Company Details
11.12.2 ICC International Cannabis Business Overview
11.12.3 ICC International Cannabis New Psychoactive Substance Introduction
11.12.4 ICC International Cannabis Revenue in New Psychoactive Substance Business (2020-2025)
11.12.5 ICC International Cannabis Recent Development
11.13 Biotii Technologies
11.13.1 Biotii Technologies Company Details
11.13.2 Biotii Technologies Business Overview
11.13.3 Biotii Technologies New Psychoactive Substance Introduction
11.13.4 Biotii Technologies Revenue in New Psychoactive Substance Business (2020-2025)
11.13.5 Biotii Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies
List of Tables
 Table 1. Global New Psychoactive Substance Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stimulants
 Table 3. Key Players of Cannabinoids
 Table 4. Key Players of Hallucinogens
 Table 5. Key Players of Depressants
 Table 6. Global New Psychoactive Substance Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global New Psychoactive Substance Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global New Psychoactive Substance Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global New Psychoactive Substance Market Share by Region (2020-2025)
 Table 10. Global New Psychoactive Substance Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global New Psychoactive Substance Market Share by Region (2026-2031)
 Table 12. New Psychoactive Substance Market Trends
 Table 13. New Psychoactive Substance Market Drivers
 Table 14. New Psychoactive Substance Market Challenges
 Table 15. New Psychoactive Substance Market Restraints
 Table 16. Global New Psychoactive Substance Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global New Psychoactive Substance Market Share by Players (2020-2025)
 Table 18. Global Top New Psychoactive Substance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2024)
 Table 19. Ranking of Global Top New Psychoactive Substance Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by New Psychoactive Substance Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of New Psychoactive Substance, Headquarters and Area Served
 Table 22. Global Key Players of New Psychoactive Substance, Product and Application
 Table 23. Global Key Players of New Psychoactive Substance, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global New Psychoactive Substance Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global New Psychoactive Substance Revenue Market Share by Type (2020-2025)
 Table 27. Global New Psychoactive Substance Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global New Psychoactive Substance Revenue Market Share by Type (2026-2031)
 Table 29. Global New Psychoactive Substance Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global New Psychoactive Substance Revenue Market Share by Application (2020-2025)
 Table 31. Global New Psychoactive Substance Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global New Psychoactive Substance Revenue Market Share by Application (2026-2031)
 Table 33. North America New Psychoactive Substance Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America New Psychoactive Substance Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America New Psychoactive Substance Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe New Psychoactive Substance Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe New Psychoactive Substance Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe New Psychoactive Substance Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific New Psychoactive Substance Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific New Psychoactive Substance Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific New Psychoactive Substance Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America New Psychoactive Substance Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America New Psychoactive Substance Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America New Psychoactive Substance Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa New Psychoactive Substance Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa New Psychoactive Substance Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa New Psychoactive Substance Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Zynerba Pharmaceuticals Company Details
 Table 49. Zynerba Pharmaceuticals Business Overview
 Table 50. Zynerba Pharmaceuticals New Psychoactive Substance Product
 Table 51. Zynerba Pharmaceuticals Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 52. Zynerba Pharmaceuticals Recent Development
 Table 53. GW Pharmaceuticals Company Details
 Table 54. GW Pharmaceuticals Business Overview
 Table 55. GW Pharmaceuticals New Psychoactive Substance Product
 Table 56. GW Pharmaceuticals Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 57. GW Pharmaceuticals Recent Development
 Table 58. Teewinot Life Sciences Company Details
 Table 59. Teewinot Life Sciences Business Overview
 Table 60. Teewinot Life Sciences New Psychoactive Substance Product
 Table 61. Teewinot Life Sciences Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 62. Teewinot Life Sciences Recent Development
 Table 63. AusCann Company Details
 Table 64. AusCann Business Overview
 Table 65. AusCann New Psychoactive Substance Product
 Table 66. AusCann Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 67. AusCann Recent Development
 Table 68. Cannabics Pharmaceuticals Company Details
 Table 69. Cannabics Pharmaceuticals Business Overview
 Table 70. Cannabics Pharmaceuticals New Psychoactive Substance Product
 Table 71. Cannabics Pharmaceuticals Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 72. Cannabics Pharmaceuticals Recent Development
 Table 73. Tilray Company Details
 Table 74. Tilray Business Overview
 Table 75. Tilray New Psychoactive Substance Product
 Table 76. Tilray Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 77. Tilray Recent Development
 Table 78. Cyrelian Company Details
 Table 79. Cyrelian Business Overview
 Table 80. Cyrelian New Psychoactive Substance Product
 Table 81. Cyrelian Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 82. Cyrelian Recent Development
 Table 83. Anandia Laboratories Company Details
 Table 84. Anandia Laboratories Business Overview
 Table 85. Anandia Laboratories New Psychoactive Substance Product
 Table 86. Anandia Laboratories Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 87. Anandia Laboratories Recent Development
 Table 88. InMed Pharmaceuticals Company Details
 Table 89. InMed Pharmaceuticals Business Overview
 Table 90. InMed Pharmaceuticals New Psychoactive Substance Product
 Table 91. InMed Pharmaceuticals Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 92. InMed Pharmaceuticals Recent Development
 Table 93. Renew Biopharma Company Details
 Table 94. Renew Biopharma Business Overview
 Table 95. Renew Biopharma New Psychoactive Substance Product
 Table 96. Renew Biopharma Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 97. Renew Biopharma Recent Development
 Table 98. Cronos Group Company Details
 Table 99. Cronos Group Business Overview
 Table 100. Cronos Group New Psychoactive Substance Product
 Table 101. Cronos Group Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 102. Cronos Group Recent Development
 Table 103. ICC International Cannabis Company Details
 Table 104. ICC International Cannabis Business Overview
 Table 105. ICC International Cannabis New Psychoactive Substance Product
 Table 106. ICC International Cannabis Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 107. ICC International Cannabis Recent Development
 Table 108. Biotii Technologies Company Details
 Table 109. Biotii Technologies Business Overview
 Table 110. Biotii Technologies New Psychoactive Substance Product
 Table 111. Biotii Technologies Revenue in New Psychoactive Substance Business (2020-2025) & (US$ Million)
 Table 112. Biotii Technologies Recent Development
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. New Psychoactive Substance Picture
 Figure 2. Global New Psychoactive Substance Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global New Psychoactive Substance Market Share by Type: 2024 VS 2031
 Figure 4. Stimulants Features
 Figure 5. Cannabinoids Features
 Figure 6. Hallucinogens Features
 Figure 7. Depressants Features
 Figure 8. Global New Psychoactive Substance Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global New Psychoactive Substance Market Share by Application: 2024 VS 2031
 Figure 10. Cancer Case Studies
 Figure 11. Neuropathic Disorders Case Studies
 Figure 12. Spasticity Case Studies
 Figure 13. Others Case Studies
 Figure 14. New Psychoactive Substance Report Years Considered
 Figure 15. Global New Psychoactive Substance Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global New Psychoactive Substance Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global New Psychoactive Substance Market Share by Region: 2024 VS 2031
 Figure 18. Global New Psychoactive Substance Market Share by Players in 2024
 Figure 19. Global Top New Psychoactive Substance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by New Psychoactive Substance Revenue in 2024
 Figure 21. North America New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America New Psychoactive Substance Market Share by Country (2020-2031)
 Figure 23. United States New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe New Psychoactive Substance Market Share by Country (2020-2031)
 Figure 27. Germany New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific New Psychoactive Substance Market Share by Region (2020-2031)
 Figure 35. China New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America New Psychoactive Substance Market Share by Country (2020-2031)
 Figure 43. Mexico New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa New Psychoactive Substance Market Share by Country (2020-2031)
 Figure 47. Turkey New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE New Psychoactive Substance Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Zynerba Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 51. GW Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 52. Teewinot Life Sciences Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 53. AusCann Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 54. Cannabics Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 55. Tilray Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 56. Cyrelian Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 57. Anandia Laboratories Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 58. InMed Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 59. Renew Biopharma Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 60. Cronos Group Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 61. ICC International Cannabis Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 62. Biotii Technologies Revenue Growth Rate in New Psychoactive Substance Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Psychoactive Substances Market Research Report 2024
Global Psychotherapeutics Drugs Market Research Report 2024
Global Cannabis Drug Market Research Report 2024
Global Psychobiotics Market Research Report 2024
Global Psychotherapeutic Drugs Market Research Report 2024
Global New Media Market Research Report 2024
Psychotropic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recreational Marijuana Market Research Report 2024
Global Biogenic Stimulant Market Research Report 2024
Global Alcohol Market Research Report 2024
Global Psychiatric and Nervous Drugs Market Research Report 2025
Global Marine based Drug Market Research Report 2024
Global Psychobiotic Supplements Market Research Report 2024
Global Opium Market Research Report 2025
Global Cannabis Growing Market Research Report 2025
Recreational Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anxiolytic Drugs Market Research Report 2025
Global Pharmacokinetic Research Market Research Report 2024
Global Sex Products Market Research Report 2024
Global HIV Prevention Drug Market Research Report 2024

RELATED REPORTS

Global Ballistic Targeting System Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3L6393
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Non-lethal Grenades Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38D19545
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Gun Shop Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y2404
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Army Knives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20A1573
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions